 Effect aldose reductase inhibition resistance conduction block diabetic subjects OBJECTIVE effect aldose reductase inhibition ponalrestat resistance conduction block RICB diabetic subjects RESEARCH DESIGN AND METHODS healthy diabetic subjects neuropathy Subjects double-blind trial mg ponalrestat placebo daily wk median nerve action potential MNAP conduction velocity NCV min forearm ischemia start finish study Results RICB MNAP ischemia ponalrestat-treated group placebo-treated group MNAP NCV unchanged groups CONCLUSIONS Aldose reductase inhibition ponalrestat RICB diabetes nerve hypoxia nerve energy substrates